Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy

Paeoniflorin (PF) is the primary component of total glucosides of paeony (TGP). It exerts multiple effects, including immunoregulatory and anti-inflammatory effects. Our previous study has found that PF has a remarkable renal-protective effect in diabetic mice, but exact mechanism has not been clari...

Full description

Bibliographic Details
Main Authors: Yun-xia Shao, Qian Gong, Xiang-Ming Qi, Kun Wang, Yong-gui Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00566/full
id doaj-5f66bc4a4ab1491cb9d38d9aef73c9f8
record_format Article
spelling doaj-5f66bc4a4ab1491cb9d38d9aef73c9f82020-11-25T02:35:00ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-05-011010.3389/fphar.2019.00566391183Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic NephropathyYun-xia Shao0Yun-xia Shao1Qian Gong2Xiang-Ming Qi3Kun Wang4Yong-gui Wu5Department of Nephrology, The First Affiliated Hospital, Anhui Medical University Hefei, Hefei, ChinaDepartment of Nephrology, The Second People’s Hospital of Wuhu, Wuhu, ChinaDepartment of Nephrology, The First Affiliated Hospital, Anhui Medical University Hefei, Hefei, ChinaDepartment of Nephrology, The First Affiliated Hospital, Anhui Medical University Hefei, Hefei, ChinaDepartment of Nephrology, The First Affiliated Hospital, Anhui Medical University Hefei, Hefei, ChinaDepartment of Nephrology, The First Affiliated Hospital, Anhui Medical University Hefei, Hefei, ChinaPaeoniflorin (PF) is the primary component of total glucosides of paeony (TGP). It exerts multiple effects, including immunoregulatory and anti-inflammatory effects. Our previous study has found that PF has a remarkable renal-protective effect in diabetic mice, but exact mechanism has not been clarified. This study mainly explores whether PF affects macrophage infiltration and activation in diabetic kidney through TLR4 pathway. Thus, this study was conducted to investigate the effect of PF on a streptozotocin (STZ)-induced experimental DN model. The results suggested that the onset and clinical symptoms of DN in mice were remarkably ameliorated after the administration of PF. Moreover, the number of infiltrating macrophages in the mouse kidneys was also markedly decreased. Instead of inhibiting the activation of macrophages directly, PF could influence macrophages by suppressing iNOS expression as well as the production of TNF-α, IL-1β, and MCP-1 both in vivo and in vitro. These effects might be attributable to the inhibition of the TLR4 signaling pathway. The percentage of M1-phenotype cells as well as the mRNA levels of iNOS, TNF-α, IL-1β, and MCP-1 were downregulated when PF-treated polarized macrophages were cultured under conditions of high glucose (HG) levels. In addition, the expression of TLR4, along with that of downstream signaling molecule proteins, was also reduced. Our study has provided new insights into the potential of PF as a promising therapeutic agent for treating DN and has illustrated the underlying mechanism of PF from a new perspective.https://www.frontiersin.org/article/10.3389/fphar.2019.00566/fullpaeoniflorintoll-like receptor 4macrophagesdiabetic nephropathyinflammation
collection DOAJ
language English
format Article
sources DOAJ
author Yun-xia Shao
Yun-xia Shao
Qian Gong
Xiang-Ming Qi
Kun Wang
Yong-gui Wu
spellingShingle Yun-xia Shao
Yun-xia Shao
Qian Gong
Xiang-Ming Qi
Kun Wang
Yong-gui Wu
Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
Frontiers in Pharmacology
paeoniflorin
toll-like receptor 4
macrophages
diabetic nephropathy
inflammation
author_facet Yun-xia Shao
Yun-xia Shao
Qian Gong
Xiang-Ming Qi
Kun Wang
Yong-gui Wu
author_sort Yun-xia Shao
title Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
title_short Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
title_full Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
title_fullStr Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
title_full_unstemmed Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
title_sort paeoniflorin ameliorates macrophage infiltration and activation by inhibiting the tlr4 signaling pathway in diabetic nephropathy
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2019-05-01
description Paeoniflorin (PF) is the primary component of total glucosides of paeony (TGP). It exerts multiple effects, including immunoregulatory and anti-inflammatory effects. Our previous study has found that PF has a remarkable renal-protective effect in diabetic mice, but exact mechanism has not been clarified. This study mainly explores whether PF affects macrophage infiltration and activation in diabetic kidney through TLR4 pathway. Thus, this study was conducted to investigate the effect of PF on a streptozotocin (STZ)-induced experimental DN model. The results suggested that the onset and clinical symptoms of DN in mice were remarkably ameliorated after the administration of PF. Moreover, the number of infiltrating macrophages in the mouse kidneys was also markedly decreased. Instead of inhibiting the activation of macrophages directly, PF could influence macrophages by suppressing iNOS expression as well as the production of TNF-α, IL-1β, and MCP-1 both in vivo and in vitro. These effects might be attributable to the inhibition of the TLR4 signaling pathway. The percentage of M1-phenotype cells as well as the mRNA levels of iNOS, TNF-α, IL-1β, and MCP-1 were downregulated when PF-treated polarized macrophages were cultured under conditions of high glucose (HG) levels. In addition, the expression of TLR4, along with that of downstream signaling molecule proteins, was also reduced. Our study has provided new insights into the potential of PF as a promising therapeutic agent for treating DN and has illustrated the underlying mechanism of PF from a new perspective.
topic paeoniflorin
toll-like receptor 4
macrophages
diabetic nephropathy
inflammation
url https://www.frontiersin.org/article/10.3389/fphar.2019.00566/full
work_keys_str_mv AT yunxiashao paeoniflorinamelioratesmacrophageinfiltrationandactivationbyinhibitingthetlr4signalingpathwayindiabeticnephropathy
AT yunxiashao paeoniflorinamelioratesmacrophageinfiltrationandactivationbyinhibitingthetlr4signalingpathwayindiabeticnephropathy
AT qiangong paeoniflorinamelioratesmacrophageinfiltrationandactivationbyinhibitingthetlr4signalingpathwayindiabeticnephropathy
AT xiangmingqi paeoniflorinamelioratesmacrophageinfiltrationandactivationbyinhibitingthetlr4signalingpathwayindiabeticnephropathy
AT kunwang paeoniflorinamelioratesmacrophageinfiltrationandactivationbyinhibitingthetlr4signalingpathwayindiabeticnephropathy
AT yongguiwu paeoniflorinamelioratesmacrophageinfiltrationandactivationbyinhibitingthetlr4signalingpathwayindiabeticnephropathy
_version_ 1724805810920357888